Caxton Corp as of March 31, 2020
Portfolio Holdings for Caxton Corp
Caxton Corp holds 17 positions in its portfolio as reported in the March 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Molecular Templates | 30.6 | $28M | 2.1M | 13.29 | |
Kala Pharmaceuticals | 17.6 | $16M | 1.8M | 8.79 | |
Satsuma Pharmaceuticals Ord | 14.3 | $13M | 606k | 21.52 | |
Strongbridge Biopharma Shs Usd | 13.7 | $13M | 6.6M | 1.89 | |
Sierra Oncology Com New | 6.9 | $6.3M | 644k | 9.82 | |
Scynexis | 6.8 | $6.2M | 7.9M | 0.78 | |
Sunesis Pharmaceuticals Com Par | 3.7 | $3.4M | 8.1M | 0.41 | |
Garrison Capital | 2.2 | $2.0M | 1.2M | 1.70 | |
Mei Pharma Com New | 1.6 | $1.4M | 886k | 1.61 | |
Cti Biopharma Corp Com New | 0.6 | $567k | 617k | 0.92 | |
Eiger Biopharmaceuticals | 0.6 | $555k | 82k | 6.80 | |
Fs Investment Corporation | 0.6 | $511k | 170k | 3.00 | |
Crescent Capital Bdc (CCAP) | 0.4 | $332k | 34k | 9.65 | |
Kura Oncology (KURA) | 0.2 | $222k | 22k | 9.95 | |
Calumet Specialty Prods Ptnr Ut Ltd Partner (CLMT) | 0.2 | $138k | 131k | 1.05 | |
Addex Therapeutics Sponsored Ads | 0.1 | $115k | 17k | 6.60 | |
Glycomimetics (GLYC) | 0.0 | $34k | 15k | 2.25 |